pI: 4.8549 |
Length (AA): 245 |
MW (Da): 27897 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
91 | 242 | 6cyo (A) | 0 | 151 | 77.00 | 0 | 1 | 1.71311 | -2.3 |
92 | 241 | 2aak (A) | 1 | 150 | 71.00 | 0 | 1 | 1.62694 | -2.12 |
96 | 233 | 4m1n (A) | 4 | 149 | 43.00 | 0 | 1 | 1.26577 | -2.35 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127153)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G02760 | ubiquitin-conjugating enzyme E2 A |
Arabidopsis thaliana | AT5G62540 | ubiquitin-conjugating enzyme E2 3 |
Arabidopsis thaliana | AT1G14400 | ubiquitin-conjugating enzyme E2 1 |
Babesia bovis | BBOV_II004660 | ubiquitin-conjugating enzyme, putative |
Babesia bovis | BBOV_III003380 | ubiquitin-conjugating enzyme family protein |
Brugia malayi | Bm1_31535 | Ubiquitin-conjugating enzyme E2 1 |
Candida albicans | CaO19_7195 | hypothetical protein |
Candida albicans | CaO19.7195 | 3' exon of ubiquitin-conjugating enzyme gene |
Caenorhabditis elegans | CELE_C35B1.1 | Protein UBC-1 |
Cryptosporidium hominis | Chro.60479 | ubiquitin-conjugating enzyme |
Cryptosporidium parvum | cgd6_4180 | ubiquitin-conjugating enzyme |
Cryptosporidium parvum | cgd3_2670 | protein with UBC domain, ubiquitin conjugating enzyme E2 |
Dictyostelium discoideum | DDB_G0275787 | ubiquitin-conjugating enzyme E2 |
Drosophila melanogaster | Dmel_CG2013 | Ubiquitin conjugating enzyme |
Echinococcus granulosus | EgrG_000834100 | ubiquitin conjugating enzyme rad6 |
Echinococcus granulosus | EgrG_000208000 | ubiquitin conjugating enzyme E2 A |
Entamoeba histolytica | EHI_147700 | ubiquitin-conjugating enzyme family protein |
Echinococcus multilocularis | EmuJ_000834100 | ubiquitin conjugating enzyme rad6 |
Echinococcus multilocularis | EmuJ_000208000 | ubiquitin conjugating enzyme E2 A |
Giardia lamblia | GL50803_2876 | UBC2, putative |
Giardia lamblia | GL50803_12950 | Ubiquitin-conjugating enzyme E2-17 kDa |
Giardia lamblia | GL50803_15162 | Ubiquitin-conjugating enzyme E2-17 kDa |
Homo sapiens | ENSG00000077721 | ubiquitin-conjugating enzyme E2A |
Homo sapiens | ENSG00000119048 | ubiquitin-conjugating enzyme E2B |
Leishmania braziliensis | LbrM.22.0550 | ubiquitin-conjugating enzyme-like protein |
Leishmania donovani | LdBPK_220480.1 | ubiquitin-conjugating enzyme-like protein |
Leishmania infantum | LinJ.22.0480 | ubiquitin-conjugating enzyme-like protein |
Leishmania major | LmjF.22.0610 | ubiquitin-conjugating enzyme-like protein |
Leishmania mexicana | LmxM.22.0610 | ubiquitin-conjugating enzyme-like protein |
Loa Loa (eye worm) | LOAG_02518 | ubiquitin-conjugating enzyme E2 1 |
Mus musculus | ENSMUSG00000020390 | ubiquitin-conjugating enzyme E2B |
Mus musculus | ENSMUSG00000016308 | ubiquitin-conjugating enzyme E2A |
Neospora caninum | NCLIV_060020 | Ubiquitin carrier protein (EC 6.3.2.-), related |
Neospora caninum | NCLIV_024450 | ubiquitin-conjugating enzyme e2, putative |
Oryza sativa | 4334386 | Os03g0791800 |
Oryza sativa | 4342488 | Os07g0166800 |
Oryza sativa | 4337993 | Os05g0182500 |
Plasmodium berghei | PBANKA_0806000 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium berghei | PBANKA_1424900 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium falciparum | PF3D7_0319300 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium falciparum | PF3D7_0812600 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium knowlesi | PKNH_0821900 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium knowlesi | PKNH_1428000 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium vivax | PVX_123140 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium vivax | PVX_095270 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium yoelii | PY01792 | ubiquitin-conjugating enzyme |
Plasmodium yoelii | PY00971 | putative ubiquitin-conjugating enzyme |
Saccharomyces cerevisiae | YGL058W | E2 ubiquitin-conjugating protein RAD6 |
Schistosoma japonicum | Sjp_0030560 | ko:K10573 ubiquitin-conjugating enzyme E2 A, putative |
Schistosoma japonicum | Sjp_0057640 | ko:K10573 ubiquitin-conjugating enzyme E2 A, putative |
Schistosoma mansoni | Smp_118220 | ubiquitin-conjugating enzyme rad6 |
Schistosoma mansoni | Smp_169440 | ubiquitin-conjugating enzyme rad6 |
Schmidtea mediterranea | mk4.000743.04 | Ubiquitin-conjugating enzyme E2-17 kDa |
Schmidtea mediterranea | mk4.010792.00 | Ubiquitin-conjugating enzyme E2 1 |
Trypanosoma brucei gambiense | Tbg972.7.2830 | ubiquitin-conjugating enzyme e2, putative,ubiquitin carrier protein, putative,ubiquitin-protein ligase, putative |
Trypanosoma brucei | Tb927.7.2540 | ubiquitin-protein ligase, putative |
Trypanosoma congolense | TcIL3000_7_1880 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma congolense | TcIL3000_0_55090 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma cruzi | TcCLB.506859.10 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma cruzi | TcCLB.511813.20 | ubiquitin-conjugating enzyme E2, putative |
Toxoplasma gondii | TGME49_216130 | ubiquitin conjugating enzyme E2, putative |
Toxoplasma gondii | TGME49_263490 | ubiquitin conjugating enzyme E2, putative |
Theileria parva | TP03_0333 | hypothetical protein, conserved |
Theileria parva | TP02_0288 | ubiquitin-protein ligase, putative |
Trichomonas vaginalis | TVAG_085460 | ubiquitin-conjugating enzyme E2r, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.2540 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.2540 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.2540 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.2540 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C35B1.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C35B1.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C35B1.1 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0806000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_263490 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_216130 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_263490 | Toxoplasma gondii | Probably essential | sidik |
TGME49_216130 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.